Helena Hansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helena Hansen has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
John Rotrosen
3 shared publications- Carole Siegel
Department of Psychiatry NYU School of Medicine York New NY USA
2 shared publications Danae DiRocco
University of Maryland, Department of Psychiatry, United States
2 shared publications- Seth M. Holmes
University of California, Berkeley, USA
2 shared publications - Sonia Mendoza
Department of Psychiatry,New York University,New York,New York
2 shared publications - Anne E. Becker
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- 30 November 2017
- Published by SAGE Publications in Contemporary Drug Problems
- Vol. 44 (4) , 321-338
Assisted Technologies of Social Reproduction
This article examines the symbolic work of gender as it intersects with race and class in popular media and in local community discourses surrounding the “suburban opioid epidemic,” in which national drug policies, and White futures, are thought to be at stake. The study starts with an analysis of the White, middle-class, female “new face of addiction” that has been cultivated by national press coverage of prescription opioid-cum-heroin overdoses in the U.S. and then turns to interviews with community physicians in the front line of a clinical response to the “epidemic” in Staten Island, a White suburban enclave within New York City that is experiencing 3–4 times the opioid overdose rate of any other City borough. Physicians use the language of family membership to indicate identification with their opioid addiction patients, and many go to lengths to provide holistic care and to incorporate family support for their patients despite lack of insurance reimbursement. White, educated patients describe buprenorphine as a way to maintain their professional identities, while low-income Black and Latino patients describe pharmaceutical maintenance as a socially alienating arm of the criminal justice system. Together, media and clinical responses make up strategies of White racial rescue from threatened social reproduction in an era of substance-induced White downward mobility.
- 30 November 2017
- Published by SAGE Publications in Contemporary Drug Problems
- Vol. 44 (4) , 321-338
Assisted Technologies of Social Reproduction
This article examines the symbolic work of gender as it intersects with race and class in popular media and in local community discourses surrounding the “suburban opioid epidemic,” in which national drug policies, and White futures, are thought to be at stake. The study starts with an analysis of the White, middle-class, female “new face of addiction” that has been cultivated by national press coverage of prescription opioid-cum-heroin overdoses in the U.S. and then turns to interviews with community physicians in the front line of a clinical response to the “epidemic” in Staten Island, a White suburban enclave within New York City that is experiencing 3–4 times the opioid overdose rate of any other City borough. Physicians use the language of family membership to indicate identification with their opioid addiction patients, and many go to lengths to provide holistic care and to incorporate family support for their patients despite lack of insurance reimbursement. White, educated patients describe buprenorphine as a way to maintain their professional identities, while low-income Black and Latino patients describe pharmaceutical maintenance as a socially alienating arm of the criminal justice system. Together, media and clinical responses make up strategies of White racial rescue from threatened social reproduction in an era of substance-induced White downward mobility.
- 1 March 2017
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 92 (3) , 279-281
New Medicine for the U.S. Health Care System: Training Physicians for Structural Interventions
Structural competency provides a language and theoretical framework to promote institutional-level interventions by clinical practitioners working with community organizations, non-health-sector institutions, and policy makers. The special collection of articles on structural competency in this issue of Academic Medicine addresses the need to move from theory to an appraisal of core educational interventions that operationalize the goals of and foster structural competency. In this Commentary, the authors review the role of clinical practitioners in enhancing population-level health outcomes through collaborations with professionals in fields outside medicine, including the social sciences and law. They describe the core elements of structural competency in preclinical and clinical education, as illustrated by the articles of this special collection: perceiving the structural causes of patients’ disease, envisioning structural interventions, and cultivating alliances with non-health-sector agencies that can implement structural interventions. Finally, the authors argue that preparing trainees to form partnerships will empower them to influence the social determinants of their patients’ health and reduce health inequalities.
- 1 March 2017
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 92 (3) , 279-281
New Medicine for the U.S. Health Care System: Training Physicians for Structural Interventions
Structural competency provides a language and theoretical framework to promote institutional-level interventions by clinical practitioners working with community organizations, non-health-sector institutions, and policy makers. The special collection of articles on structural competency in this issue of Academic Medicine addresses the need to move from theory to an appraisal of core educational interventions that operationalize the goals of and foster structural competency. In this Commentary, the authors review the role of clinical practitioners in enhancing population-level health outcomes through collaborations with professionals in fields outside medicine, including the social sciences and law. They describe the core elements of structural competency in preclinical and clinical education, as illustrated by the articles of this special collection: perceiving the structural causes of patients’ disease, envisioning structural interventions, and cultivating alliances with non-health-sector agencies that can implement structural interventions. Finally, the authors argue that preparing trainees to form partnerships will empower them to influence the social determinants of their patients’ health and reduce health inequalities.
- 1 December 2016
- Published by American Public Health Association in American Journal of Public Health
- Vol. 106 (12) , 2127-2129
Is the Prescription Opioid Epidemic a White Problem?
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) Is the Prescription Opioid Epidemic a White Problem?, an article from American Journal of Public Health, Vol 106 Issue 12
- 1 December 2016
- Published by American Public Health Association in American Journal of Public Health
- Vol. 106 (12) , 2127-2129
Is the Prescription Opioid Epidemic a White Problem?
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) Is the Prescription Opioid Epidemic a White Problem?, an article from American Journal of Public Health, Vol 106 Issue 12
- 1 July 2016
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 164, 14-21
Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City
- 1 July 2016
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 164, 14-21
Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City
- 13 May 2016
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 13 (2) , 179-183
Structural Competency in the U.S. Healthcare Crisis: Putting Social and Policy Interventions Into Clinical Practice
This symposium of the Journal of Bioethical Inquiry illustrates structural competency: how clinical practitioners can intervene on social and institutional determinants of health. It will require training clinicians to see and act on structural barriers to health, to adapt imaginative structural approaches from fields outside of medicine, and to collaborate with disciplines and institutions outside of medicine. Case studies of effective work on all of these levels are presented in this volume. The contributors exemplify structural competency from many angles, from the implications of epigenetics for environmental intervention in personalized medicine to the ways clinicians can act on fundamental causes of disease, address abuses of power in clinical training, racially desegregate cities to reduce health disparities, address the systemic causes of torture by police, and implement harm-reduction programs for addiction in the face of punitive drug laws. Together, these contributors demonstrate the unique roles that clinicians can play in breaking systemic barriers to health and the benefit to the U.S. healthcare system of adopting innovations from outside of the United States and outside of clinical medicine.
- 13 May 2016
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 13 (2) , 179-183
Structural Competency in the U.S. Healthcare Crisis: Putting Social and Policy Interventions Into Clinical Practice
This symposium of the Journal of Bioethical Inquiry illustrates structural competency: how clinical practitioners can intervene on social and institutional determinants of health. It will require training clinicians to see and act on structural barriers to health, to adapt imaginative structural approaches from fields outside of medicine, and to collaborate with disciplines and institutions outside of medicine. Case studies of effective work on all of these levels are presented in this volume. The contributors exemplify structural competency from many angles, from the implications of epigenetics for environmental intervention in personalized medicine to the ways clinicians can act on fundamental causes of disease, address abuses of power in clinical training, racially desegregate cities to reduce health disparities, address the systemic causes of torture by police, and implement harm-reduction programs for addiction in the face of punitive drug laws. Together, these contributors demonstrate the unique roles that clinicians can play in breaking systemic barriers to health and the benefit to the U.S. healthcare system of adopting innovations from outside of the United States and outside of clinical medicine.
- 1 November 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 156, e89
Impact of prescription monitoring on care of opioid-dependent patients
- 1 November 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 156, e89
Impact of prescription monitoring on care of opioid-dependent patients
- 1 January 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 146, e134
Buprenorphine dissemination in the public sector: Social network analysis and institutional constraints of prescribers in New York City
- 1 January 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 146, e134
Buprenorphine dissemination in the public sector: Social network analysis and institutional constraints of prescribers in New York City
- 28 August 2014
- Published by Springer Nature in Journal of Urban Health
- Vol. 91 (5) , 999-1008
Effects of Regulation on Methadone and Buprenorphine Provision in the Wake of Hurricane Sandy
Hurricane Sandy led to the closing of many major New York City public hospitals including their substance abuse clinics and methadone programs, and the displacement or relocation of thousands of opioid-dependent patients from treatment. The disaster provided a natural experiment that revealed the relative strengths and weaknesses of methadone treatment in comparison to physician office-based buprenorphine treatment for opioid dependence, two modalities of opioid maintenance with markedly different regulatory requirements and institutional procedures. To assess these two modalities of treatment under emergency conditions, semi-structured interviews about barriers to and facilitators of continuity of care for methadone and buprenorphine patients were conducted with 50 providers of opioid maintenance treatment. Major findings included that methadone programs presented more regulatory barriers for providers, difficulty with dose verification due to impaired communication, and an over reliance on emergency room dosing leading to unsafe or suboptimal dosing. Buprenorphine treatment presented fewer regulatory barriers, but buprenorphine providers had little to no cross-coverage options compared to methadone providers, who could refer to alternate methadone programs. The findings point to the need for well-defined emergency procedures with flexibility around regulations, the need for a central registry with patient dose information, as well as stronger professional networks and cross-coverage procedures. These interventions would improve day-to-day services for opioid-maintained patients as well as services under emergency conditions.
- 28 August 2014
- Published by Springer Nature in Journal of Urban Health
- Vol. 91 (5) , 999-1008
Effects of Regulation on Methadone and Buprenorphine Provision in the Wake of Hurricane Sandy
Hurricane Sandy led to the closing of many major New York City public hospitals including their substance abuse clinics and methadone programs, and the displacement or relocation of thousands of opioid-dependent patients from treatment. The disaster provided a natural experiment that revealed the relative strengths and weaknesses of methadone treatment in comparison to physician office-based buprenorphine treatment for opioid dependence, two modalities of opioid maintenance with markedly different regulatory requirements and institutional procedures. To assess these two modalities of treatment under emergency conditions, semi-structured interviews about barriers to and facilitators of continuity of care for methadone and buprenorphine patients were conducted with 50 providers of opioid maintenance treatment. Major findings included that methadone programs presented more regulatory barriers for providers, difficulty with dose verification due to impaired communication, and an over reliance on emergency room dosing leading to unsafe or suboptimal dosing. Buprenorphine treatment presented fewer regulatory barriers, but buprenorphine providers had little to no cross-coverage options compared to methadone providers, who could refer to alternate methadone programs. The findings point to the need for well-defined emergency procedures with flexibility around regulations, the need for a central registry with patient dose information, as well as stronger professional networks and cross-coverage procedures. These interventions would improve day-to-day services for opioid-maintained patients as well as services under emergency conditions.
- 1 December 2013
- Published by Elsevier in Social Science & Medicine
- Vol. 99, 116-118
Ethnography of Health for Social Change: Impact on public perception and policy
- 1 December 2013
- Published by Elsevier in Social Science & Medicine
- Vol. 99, 116-118
Ethnography of Health for Social Change: Impact on public perception and policy